Statements (80)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:acquisition |
acquired by Purdue Pharma L. P.
|
| gptkbp:advertising |
gptkb:Richard_A._Sackler
controversial advertising practices aggressive advertising campaigns for Oxy Contin |
| gptkbp:bankruptcy_plan |
restructuring plan approved
|
| gptkbp:case_analysis |
multiple lawsuits regarding opioid crisis
|
| gptkbp:ceo |
gptkb:Craig_Landau
gptkb:Mark_Timney |
| gptkbp:challenges |
reputation management
|
| gptkbp:community_impact |
significant community impact due to opioid crisis
|
| gptkbp:community_outreach |
community outreach programs
|
| gptkbp:controversy |
aggressive marketing of opioids
|
| gptkbp:convicted_of |
criminal charges
|
| gptkbp:criticism |
gptkb:healthcare_professionals
facing criticism from public health officials |
| gptkbp:discusses |
drug pricing
|
| gptkbp:employees |
approximately 1,000
|
| gptkbp:faced |
numerous lawsuits
|
| gptkbp:financial_performance |
declining financial performance post-2010
|
| gptkbp:financial_settlements |
financial settlements with federal government
|
| gptkbp:financials |
September 2019
|
| gptkbp:founded |
gptkb:1996
|
| gptkbp:founded_in |
gptkb:1996
|
| gptkbp:founder |
gptkb:John_Purdue_Gray
|
| gptkbp:future_plans |
plans to focus on addiction treatment
|
| gptkbp:has_been_accused_of |
contributing to the opioid epidemic
|
| gptkbp:has_been_scrutinized_by |
government agencies
|
| gptkbp:has_faced_bankruptcy_due_to |
lawsuits
|
| gptkbp:has_faced_lawsuits_from |
individuals and families
|
| gptkbp:has_history |
controversial practices
|
| gptkbp:has_settlements_with |
various states
|
| gptkbp:has_undergone_changes_in |
leadership due to controversies
|
| gptkbp:headquartered_in |
gptkb:Stamford,_Connecticut
|
| gptkbp:headquarters |
gptkb:Stamford,_Connecticut
|
| https://www.w3.org/2000/01/rdf-schema#label |
Purdue Pharma
|
| gptkbp:impact |
significant impact on opioid epidemic
|
| gptkbp:industry |
gptkb:pharmaceuticals
|
| gptkbp:investigates |
federal investigations into practices
|
| gptkbp:investment |
investments in addiction research
|
| gptkbp:is_a_subject_of |
documentaries and reports
|
| gptkbp:is_criticized_for |
opioid prescriptions
|
| gptkbp:is_known_for |
gptkb:Oxy_Contin
|
| gptkbp:is_linked_to |
increased overdose rates
|
| gptkbp:lawsuit_settlements |
settlements with various states
|
| gptkbp:legal_issue |
ongoing legal challenges
facing criminal charges high-profile legal defense teams |
| gptkbp:legal_liabilities |
significant legal liabilities due to lawsuits
|
| gptkbp:major_city |
over $8 billion in settlements
|
| gptkbp:market |
gptkb:United_States
|
| gptkbp:notable_products |
gptkb:Oxy_Contin
|
| gptkbp:opioid_addiction |
contributed to opioid addiction crisis
|
| gptkbp:opioid_crisis |
linked to opioid crisis in the U. S.
|
| gptkbp:opioid_crisis_response |
developing response strategies to opioid crisis
|
| gptkbp:opioid_marketing |
aggressive opioid marketing strategies
|
| gptkbp:opioid_prescriptions |
increased opioid prescriptions
|
| gptkbp:opioid-related_deaths |
linked to opioid-related deaths
|
| gptkbp:parent_company |
gptkb:Purdue_Pharma_L._P.
|
| gptkbp:partnership |
with various healthcare organizations
|
| gptkbp:philanthropy |
donations to addiction treatment programs
|
| gptkbp:product_line |
pain management medications
|
| gptkbp:public_perception |
negative due to opioid crisis
|
| gptkbp:public_relations |
struggled with public relations issues
|
| gptkbp:recalls |
Oxy Contin reformulation
|
| gptkbp:reform |
reformulated Oxy Contin to deter abuse
|
| gptkbp:regulatory_compliance |
increased regulatory scrutiny
|
| gptkbp:reputation |
damaged reputation due to lawsuits
|
| gptkbp:research |
opioid medications
|
| gptkbp:revenue |
$3 billion (2018)
complex corporate structure |
| gptkbp:subsidiary |
gptkb:Purdue_Pharma_L._P.
Purdue Holdings |
| gptkbp:was_involved_in |
community outreach programs
settlements worth billions the development of Oxy Contin |
| gptkbp:website |
www.purduepharma.com
|
| gptkbp:bfsParent |
gptkb:Arthur_M._Sackler
gptkb:Eisai |
| gptkbp:bfsLayer |
5
|